System Certification ISO 9001:2000
Exbio Antibodies CZ / SK eShop
by categories | a-z list | Application type: Flow Cytometry | Immunohistochemistry | Functional Studies

Mouse Monoclonal to CD22 / BL-CAM

IS7 (IgG1)

Technical Information Request    Inquiry for Bulk Prices

Product No. Form Quantity Stock Price Datasheet Shop
  10-506-C025 azide free 0.025 mg yes choose region PDF datasheetHTML datasheet buy
  10-506-C100 azide free 0.1 mg yes choose region PDF datasheetHTML datasheet buy
  PB-506-T025 Pacific Blue™ 25 tests yes choose region PDF datasheetHTML datasheet buy
  PB-506-T100 Pacific Blue™ 100 tests yes choose region PDF datasheetHTML datasheet buy
  1F-506-T025 FITC 25 tests yes choose region PDF datasheetHTML datasheet buy
  1F-506-T100 FITC 100 tests yes choose region PDF datasheetHTML datasheet buy
  1P-506-T025 PE 25 tests yes choose region PDF datasheetHTML datasheet buy
  1P-506-T100 PE 100 tests yes choose region PDF datasheetHTML datasheet buy
  1A-506-T025 APC 25 tests yes choose region PDF datasheetHTML datasheet buy
  1A-506-T100 APC 100 tests yes choose region PDF datasheetHTML datasheet buy
  A7-506-T025 Alexa Fluor® 700 25 tests yes choose region PDF datasheetHTML datasheet buy
  A7-506-T100 Alexa Fluor® 700 100 tests yes choose region PDF datasheetHTML datasheet buy
- In stock! Ready for immediate despatch - Manufacture on order

Background

CD22, also known as Siglec-2 (sialic acid-binding immunoglobulin-like lectin-2) is a transmembrane glycoprotein binding alpha2,6-linked sialic acid-bearing ligands. Intracellular domain of CD22 recruits protein tyrosine phosphatase SHP-1 through the immunoreceptor tyrosine-based inhibitory motifs (ITIMs), thus setting a treshold for B cell receptor-mediated activation. CD22 also regulates B-cell response by involvement in controlling the CD19/CD21-Src-family protein tyrosine kinase amplification pathway and CD40 signaling. CD22 exhibits hallmarks of clathrin-mediated endocytic pathway.

Specificity

The antibody IS7 reacts with CD22 (BL-CAM), a 130 kDa type I transmembrane glycoprotein (immunoglobulin superfamily) expressed in the cytoplasm of pro-B and pre-B lymphocytes, and on the surface of mature and activated B lymphocytes; it is lost on plasma cells, peripheral blood T lymphocytes, granulocytes and monocytes.
HLDA IV; WS Code B 227
HLDA V; WS Code B CD22.8

Immunogen

Reh human cell line

Species Reactivity:

  • Human

Negative Species:

Applications:

  • Flow Cytometry
    Positive control: lysed whole blood
    Application note: lyse, wash protocol
Usage note:
Indicated dilutions are recommended starting points for use of this product. Working concentrations should be determined by the investigator.

General references

  • *Tedder TF, Poe JC, Haas KM: CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction. Adv Immunol. 2005;88:1-50. [Abstract]
  • *Tateno H, Li H, Schur MJ, Bovin N, Crocker PR, Wakarchuk WW, Paulson JC: Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity. Mol Cell Biol. 2007 Aug;27(16):5699-710. [Abstract] [Full Text]
  • *Walker JA, Smith KG: CD22: an inhibitory enigma. Immunology. 2007 Dec 7 [Abstract]
  • Product Specific References

  • *Leukocyte Typing IV., Knapp W. et al. (Eds.), Oxford University Press (1989).
  • *Leukocyte Typing V., Schlossman S. et al. (Eds.), Oxford University Press (1995).
  • For research use only. Not for drug, diagnostic or other use.

    Related Products

  • Mouse IgG1 Isotype Control
  • Example Data

    Alexa Fluor®, Pacific Blue™ and Pacific Orange™ are registred trademarks of Molecular Probes Inc., Eugene, OR, USA. (licence label)
    DyLight™ is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
    Cy5, Cy5.5 and Cy7 conjugates are made and sold under license from GE Healthcare Bio-Sciences Corp. The conjugates are licensed for non-commercial research use only. Not for therapeutic or in vivo applications. Other use needs license from GE Healthcare Bio-Sciences Corp. under U.S. patent Nos. 5 569 587 and 5 627 027 and other patents pending.
    © 2003 EXBIO. All rights reserved.
    terms and conditions | privacy policy